EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease

Norma David, Jean-Philippe Antignac, Marine Roux, Philippe Marchand, Sophie Michalak, Fréderic Oberti, Isabelle Fouchard, Adrien Lannes, Odile Blanchet, Paul Cales, Etienne B Blanc, Jérôme Boursier und 1 weitere

Environment International · 2023-10 · 180 · 108235

DOI: 10.1016/j.envint.2023.108235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environment International, 2023-10. Verfasst von Norma David und 12 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Hépato-Gastroentérologie et Oncologie Digestive, Centre Hospitalier Universitaire d'Angers, Angers, France. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Fluorocarbons, Environmental Pollutants. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver disease worldwide and the determinants driving its severity remain to be elucidated. Perfluoroalkyl substances (PFAS) are synthetic chemical compounds. They are used in commonplace products and persistent in water, soil and the human body. In vitro and animal studies suggest a pathogenic role for PFAS in metabolic diseases such as NAFLD. OBJECTIVES: We aimed to evaluate the association between NAFLD severity and serum PFAS concentrations in humans. METHODS: One hundred biopsy-proven NAFLD patients were included with a well-balanced distribution between the different stages of severity: 25 patients with simple steatosis, 25 with early non-alcoholic steatohepatitis (NASH and F0-F1 fibrosis), 33 with fibrotic NASH (NASH and F2-F3 fibrosis), and 17 with cirrhotic NASH (NASH and F4 fibrosis). Liver histological features were evaluated according to the NASH Clinical Research Network classification. Seventeen PFAS were measured by high-performance liquid chromatography coupled with tandem mass spectrometry on serum samples stored at -80 °C. RESULTS: The median age was 60 years, 61 % of patients were male, 46 % had diabetes and the median body mass index (BMI) was 32 kg/m2. Long-chain PFAS were associated with steatosis grade (p = 0.03). Among the nine PFAS detected in > 50 % of the patients, Perfluoro-n-heptanoic acid (PFHpA) showed significantly higher concentrations in grade 3 steatosis versus grade 1 (p = 0.02). Perfluoro-n-dodecanoic acid (PFDoA) concentrations were higher in patients with significant fibrosis (p = 0.04) and PFHpA in patients with advanced fibrosis (p = 0.02). The association between PFHpA and steatosis grade remained significant in multivariate analysis adjusted for age, gender, BMI, diabetes presence and dyslipidemia (p = 0.004). DISCUSSION: Our study showed a significant association between PFHpA and liver steatosis in NAFLD. According to data available in the literature, PFHpA could be implicated in liver steatosis through β-oxidation and biosynthesis of fatty acids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseFluorocarbonsEnvironmental PollutantsHumansMaleFemaleMiddle AgedAgedAdult

Stichwörter der Autor:innen

NAFLDNASHPFASPFHpA

Substanzen

FluorocarbonsEnvironmental Pollutants

Autor:innen und Institutionen

  • Service d'Hépato-Gastroentérologie et Oncologie Digestive, Centre Hospitalier Universitaire d'Angers, Angers, France.
  • Oniris, INRAE, LABERCA, Nantes, France.
  • Laboratoire HIFIH, SFR ICAT 4208, Université d'Angers, Angers, France.
  • Laboratoire HIFIH, SFR ICAT 4208, Université d'Angers, Angers, France; Service d'Anatomopathologie, Centre Hospitalier Universitaire d'Angers, Angers, France.
  • Service d'Hépato-Gastroentérologie et Oncologie Digestive, Centre Hospitalier Universitaire d'Angers, Angers, France; Laboratoire HIFIH, SFR ICAT 4208, Université d'Angers, Angers, France.
  • Centre de Ressources Biologiques BB-0033-00038, Centre Hospitalier Universitaire d'Angers, Angers, France.

Zitieren

APA

David, N., Antignac, J. P., Roux, M., Marchand, P., Michalak, S., Oberti, F., Fouchard, I., Lannes, A., Blanchet, O., Cales, P., Blanc, E. B., Boursier, J., & Canivet, C. M. (2023). Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease. Environment International, 180, 108235. https://doi.org/10.1016/j.envint.2023.108235

Vancouver

David N, Antignac JP, Roux M, Marchand P, Michalak S, Oberti F, et al. Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease. Environment International. 2023;180:108235. doi:10.1016/j.envint.2023.108235

BibTeX
@article{David2023,
  author = {David, Norma and Antignac, Jean-Philippe and Roux, Marine and Marchand, Philippe and Michalak, Sophie and Oberti, Fréderic and Fouchard, Isabelle and Lannes, Adrien and Blanchet, Odile and Cales, Paul and Blanc, Etienne B and Boursier, Jérôme and Canivet, Clémence M},
  title = {Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease},
  journal = {Environment International},
  year = {2023},
  volume = {180},
  pages = {108235},
  doi = {10.1016/j.envint.2023.108235}
}
Kostenlos starten →